10X Genomics Inc at Stephens Investment Conference Transcript
Thanks, everyone, for joining us. My name is Mason Carrico. I'm the Diagnostics and Genomics analyst at Stephens. Today, we have Justin McAnear and Cassie Corneau of 10x Genomics with us. If at any point, anyone from the audience has questions, feel free to jump in and ask away.
Questions & Answers
But we'll start with the quarter, beat and raised in a challenging environment. What are some of the key takeaways for investors to keep top of mind from the call?
Great. Well, first off, thanks for inviting us today. Very happy to be here today. In thinking about Q3, you're right. It was a solid quarter. We're proud of what the team accomplished this past quarter. As far as key takeaways, here's 3 things that we'd like to convey. The first is that we saw an acceleration of Xenium this quarter. Our approach in prioritizing
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |